Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0X7OF
|
|||
Drug Name |
PMID25991433-Compound-N2
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
VERTEX PHARMACEUTICALS INCORPORATED YANG, Xiaoqing HADIDA RUAH, Sara, S. GROOTENHUIS, Peter, D.J. VAN GOOR, Fredrick, F. BOTFIELD, Martyn, C. ZLOKARNIK, Gregor
|
|||
Structure |
Download2D MOL |
|||
Formula |
C15H16N2O2S
|
|||
Canonical SMILES |
CC1=CC(=CC(=C1)CC(=O)NC2=C(C=CS2)C(=O)N)C
|
|||
InChI |
1S/C15H16N2O2S/c1-9-5-10(2)7-11(6-9)8-13(18)17-15-12(14(16)19)3-4-20-15/h3-7H,8H2,1-2H3,(H2,16,19)(H,17,18)
|
|||
InChIKey |
DXUHHRPREFMGHI-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Mitogen-activated protein kinase (MAPK) | Target Info | Inhibitor | [1] |
Target's Patent Info | Mitogen-activated protein kinase (MAPK) | Target's Patent Info | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | c-Jun N-terminal kinase inhibitors: a patent review (2010 - 2014).Expert Opin Ther Pat. 2015;25(8):849-72. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.